Physician profile
Michael Appeadu
NPI 1902302755
$11,812.76
in general payments reported to CMS, 2019-2025
13 companies · $2,519 in 2025
The $2,519 reported for 2025 was more than what 95% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $1,226 · 2023: $5,660 · 2024: $2,218 · 2025: $2,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,348 · Food and Beverage: $5,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,348.39 |
| Food and Beverage | $5,048.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,658.41 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Infinion 16 |
| Abbott Laboratories | $4,421.54 | 2023-2024 | Proclaim, Octrode |
| Medtronic, INC. | $1,454.83 | 2022-2023 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $464.29 | 2023-2024 | Senza |
| Saluda Medical Americas, INC. | $146.49 | 2023-2024 | Evoke Scs, Evoke |
| Nalu Medical, INC. | $144.42 | 2023 | Nalu Neurostimulation System |
| Averitas Pharma INC. | $137.87 | 2023-2024 | Qutenza |
| Curonix LLC | $126.58 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $94.90 | 2021 | |
| Bioventus LLC | $52.00 | 2023 | Stimrouter Implantable Kit |
| Globus Medical, INC. | $45.30 | 2025 | Senza |
| Spr Therapeutics, INC | $42.27 | 2024-2025 | Sprint Pns System |
| Abbvie INC. | $23.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Appeadu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.